251 related articles for article (PubMed ID: 1908512)
21. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
Chen BP; Madrigal A; Parham P
J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
[TBL] [Abstract][Full Text] [Related]
22. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
[TBL] [Abstract][Full Text] [Related]
23. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells.
Killeen N; Moriarty A; Teh HS; Littman DR
J Exp Med; 1992 Jul; 176(1):89-97. PubMed ID: 1613468
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
Gao GF; Tormo J; Gerth UC; Wyer JR; McMichael AJ; Stuart DI; Bell JI; Jones EY; Jakobsen BK
Nature; 1997 Jun; 387(6633):630-4. PubMed ID: 9177355
[TBL] [Abstract][Full Text] [Related]
25. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
26. Antigen recognition by the T cell receptor is enhanced by CD8 alpha-chain binding to the alpha 3 domain of MHC class I molecules, not by signaling via the cytoplasmic domain of CD8 alpha.
Tanabe M; Karaki S; Takiguchi M; Nakauchi H
Int Immunol; 1992 Feb; 4(2):147-52. PubMed ID: 1622893
[TBL] [Abstract][Full Text] [Related]
27. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
[TBL] [Abstract][Full Text] [Related]
28. The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model.
Giblin PA; Leahy DJ; Mennone J; Kavathas PB
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1716-20. PubMed ID: 8127870
[TBL] [Abstract][Full Text] [Related]
29. HLA non-A,B,C class I genes: their structure and expression.
Heinrichs H; Orr HT
Immunol Res; 1990; 9(4):265-74. PubMed ID: 2089074
[TBL] [Abstract][Full Text] [Related]
30. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.
Salter RD; Benjamin RJ; Wesley PK; Buxton SE; Garrett TP; Clayberger C; Krensky AM; Norment AM; Littman DR; Parham P
Nature; 1990 May; 345(6270):41-6. PubMed ID: 2109837
[TBL] [Abstract][Full Text] [Related]
31. Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.
Bluestone JA; Cron RQ; Cotterman M; Houlden BA; Matis LA
J Exp Med; 1988 Nov; 168(5):1899-916. PubMed ID: 2846743
[TBL] [Abstract][Full Text] [Related]
32. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
[TBL] [Abstract][Full Text] [Related]
33. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
[TBL] [Abstract][Full Text] [Related]
34. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
35. CD4 and CD8 act as co-receptors during thymic selection of the T cell repertoire.
Zúñiga-Pflücker JC; Jones LA; Chin LT; Kruisbeek AM
Semin Immunol; 1991 May; 3(3):167-75. PubMed ID: 1909594
[TBL] [Abstract][Full Text] [Related]
36. Mutations in CD8 that affect interactions with HLA class I and monoclonal anti-CD8 antibodies.
Sanders SK; Fox RO; Kavathas P
J Exp Med; 1991 Aug; 174(2):371-9. PubMed ID: 1906921
[TBL] [Abstract][Full Text] [Related]
37. The CD8 coreceptor interaction with the alpha 3 domain of HLA class I is critical to the differentiation of human cytotoxic T-lymphocytes specific for HLA-A2 and HLA-Cw4.
Wesley PK; Clayberger C; Lyu SC; Krensky AM
Hum Immunol; 1993 Mar; 36(3):149-55. PubMed ID: 8320133
[TBL] [Abstract][Full Text] [Related]
38. Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos.
Shaikly V; Shakhawat A; Withey A; Morrison I; Taranissi M; Dealtry GB; Jabeen A; Cherry R; Fernández N
Reprod Biomed Online; 2010 Feb; 20(2):223-33. PubMed ID: 20113960
[TBL] [Abstract][Full Text] [Related]
39. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes.
Gobin SJ; Biesta P; de Steenwinkel JE; Datema G; van den Elsen PJ
J Biol Chem; 2002 Oct; 277(42):39525-31. PubMed ID: 12183445
[TBL] [Abstract][Full Text] [Related]
40. Role of the TCR binding region of the HLA class I alpha 2 domain in regulation of cell adhesion and proliferation.
Pettersen RD; Hestdal K; Lie SO; Gaudernack G
J Immunol; 1996 Feb; 156(4):1415-24. PubMed ID: 8568242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
